Exibindo 2521 - 2550 de 2729
Given the emergence of agents with the capacity to cause diseases in humans, such as the new coronavirus, the Covid-19, scientists from all over the world have begun to work hard on the search for answers on the behavior of the pathogen. The process is similar to assembling a jigsaw puzzle: at every new research, an increasingly robust set of data takes form, contributing to clarify important characteristics that are crucial to create an emergency response. Among these are fundamental questions such as the incubation time of a virus, its transmission possibilities, and its mortality rate, for…
Article
Health inequalities and challenges that science is facing nowadays were the common thread for the inaugural lecture for class 2020 at the Fiocruz National School of Public Health, held on March 4. Dr. Deisy Ventura, professor at the Faculty of Public Health of the University of São Paulo, was one of the main speakers in the event, which also had presentations from demographer Paulo Jannuzzi, from the Brazilian Institute of Geography and Statistics (IBGE), and Humberto Adami, president of the National Commission for the Truth of Black Slavery of the Federal Council of the Brazilian Bar…
Article
Esta página especial reúne as Perguntas e Respostas sobre o Coronavírus SARS-CoV-2 e a doença Covid-19 publicadas no Portal Fiocruz. Como se trata de uma doença recente, a cada momento novas descobertas estão sendo feitas. Por isso, as orientações técnicas podem mudar e é sempre importante verificar as datas de publicação dos conteúdos e buscar por informações atualizadas em sites de instituições confiáveis, como a Organização Mundial da Saúde, o Ministério da Saúde e a Fiocruz.
Navegue, tire suas dúvidas e compartilhe conteúdo de qualidade.
Para mais informações, entre em contato pelo Fale…
Páginas Institucionais para Especiais
Ten out of ten infectologists in the planet believe that one of the basic actions to avoid contamination by the Covid-19, more commonly known as coronavirus, is to stay away from large groups of people. This has led to the cancellation of numerous events such as sports events, concerts, conventions, and lessons in schools and universities. Even the healthy habit of going to the cinema has turned into a risky action. Now, what happens when you spend 365 days a year living in the middle of a crowd? This is the reality of the slums of Rio and other Brazilian cities: Rocinha, Maré, Casa Amarela…
Article
The Oswaldo Cruz Foundation (Fiocruz) will be sending a team of professionals to Portuguese-speaking countries in Africa to help organise the response to the new coronavirus pandemic. This cooperation answers to a request by the regional office of the World Health Organization (WHO) in Africa, received by Fiocruz last Sunday (March 15).
According to Fiocruz director of the Fiocruz Global Health Center, Paulo Buss, Brazilian and Portuguese professionals will be partnering up to share information and innovation on the disease and to prepare local teams for the response in different levels,…
Article
The emergence of SARS-Cov-2 virus in Wuhan, China, in December 2019 led to a local epidemic that rapidly spread to multiple countries in the world, placing remarkable challenges in surveillance and control. On March 16th, 2020, WHO declared1 that the infection associated with SARS-Cov-2, named COVID-19, had spread to more than 100 countries, with more than 160,000 confirmed cases and more than 6,000 deaths globally.
Great uncertainty remains regarding the epidemic peaks that might occur in various places where the virus has arrived due to factors such as environmental and social…
Article
O eixo Cenários Epidemiológicos, tem como objetivos: 1) permitir o acompanhamento permanente da evolução da pandemia no Brasil; 2) estimar a velocidade de espalhamento da epidemia; 3)avaliar e propor medidas populacionais de contenção ou de diminuição da velocidade de propagação; 4) contribuir para a alocação de recursos dos serviços de saúde, baseada na estimativa do número de casos graves.
As diferentes metodologias e fontes de dados utilizadas podem apresentar diferentes resultados. A avaliação conjunta e a busca de consensos é, portanto, indispensável.
Páginas Institucionais para Especiais
Em mais uma iniciativa para contribuir com o enfrentamento do avanço da Covid-19 no Brasil, a Fundação Oswaldo Cruz (Fiocruz), em parceria com o Ministério da Saúde (MS), vai construir uma unidade hospitalar de montagem rápida. O espaço contará com 200 leitos exclusivos de tratamento intensivo e semi-intensivo para pacientes graves infectados pelo novo coronavírus (Sars-CoV-2).
Os 200 leitos do Centro terão isolamento para infecções por aerossóis e serão operados em condição de assistência para pacientes em alta complexidade (foto: Divulgação Fiocruz)
O Centro Hospitalar para a…
Article
A Fiocruz coordenará, no Brasil, o ensaio clínico Solidariedade (Solidarity), da Organização Mundial da Saúde (OMS). Lançada pela OMS na última sexta-feira (20/3), a iniciativa tem como objetivo investigar a eficácia de quatro tratamentos para a Covid-19 e será implementada em 18 hospitais de 12 estados, com o apoio do Departamento de Ciência e Tecnologia (Decit) do Ministério da Saúde.
O estudo Solidarity é uma conjugação de esforços em todo o mundo, para dar uma resposta rápida sobre que medicamentos são eficazes no tratamento da Covid-19 e quais são ineficazes e não devem…
Article
Articles on the new coronavirus (Sars-CoV-2) can be published in just 24 hours in the journal Memórias do Instituto Oswaldo Cruz, one of the oldest and most respected scientific journals in Latin America.
Considering the importance of rapid data sharing during the pandemic, the journal provided an express way for the dissemination of research. Already used for work on Zika, chikungunya, yellow fever and Ebola, the Fast Track system allows publication after an editor's evaluation, while the peer review process is underway.
"The Fast Track system was launched during the Zika epidemic in Brazil…
Article
An unprecedented study, conducted by the research group on Health in the Prisions [Saúde nas Prisões] of the National School of Public Health (Ensp/Fiocruz), and coordinated by Alexandra Sánchez, through technical cooperation with the Public Prosecutor's Office/RJ, analyzed the causes of deaths in the Prison System of the State of Rio de Janeiro (2016-2017). The results indicate that infectious diseases were responsible for 30% of deaths in the prison population, followed by diseases of the circulatory system (22%), external causes (12%) and diseases of the respiratory system (10%).…
Article
In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the institution as a response to this public health crisis, from the production of tests to health care to those infected. All departments and units of the Foundation are mobilized to face the epidemics. “Fiocruz turns 120 year next May, and our anniversary will be marked by our response to this pandemics, just like the beginning of the institution was a public…
Article
On March 24, the Oswaldo Cruz Foundation launched an express approval process at the Brazilian Registry of Clinical Essays (ReBEC) for clinical research on the Covid-19. The so-called fast track may reduce the normal approval period, which normally takes up to a couple of weeks, to less than 48 hours. Scientists all over the world will be able to have quick access to the modeling of ongoing studies, thus avoiding re-working and promoting cooperation. The goal is to shorten the time between the beginning of the research, testing, and the delivery of drugs, vaccines and other…
Article
The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit will have 200 beds exclusive for intensive and semi-intensive treatment of critical patients infected with the novel coronavirus (Sars-CoV-2). Check out a 3D view here.
Built in partnership with the Brazilian Ministry of Health (MoH), the initiative will also have a diagnostic support system for all necessary tests, including…
Article
Ferramentas criadas por pesquisadores auxiliam no monitoramento da pandemia de coronavírus no Brasil
Matéria originalmente publicada na Globo.com.
Article
Fiocruz is now part of a group of more than 70 scientists and institutions of more than 30 countries in an international coalition to face the Covid-19 epidemic in countries with medium and low income. Launched last Thursday (02/04), the initiative, called Covid-19 Clinical Resarch Coalition, aims to speed up research on the new coronavirus in the areas where the virus may cause serious problems in health systems that are already fragile, resulting in a higher impact on the health of vulnerable populations.
Sharing data and equitable access to treatments, drugs and vaccines are the…
Article
Fiocruz president, Nísia Trindade Lima, attended last Wednesday (April 1st) a meeting of global health leaders requested by the director-general of the World Health Organization, Tedros Adhanom. The goal of the meeting was to discuss the advancement of control measures in different countries, share lessons learned, and, mainly, debate future challenges involving the Covid-19 pandemic.
The role of WHO in a post-quarantine transition was one of the main themes under debate. Isolation measures currently affect more than one third of the world’s population. The group of about 30 leaders of…
Article
A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening of the clinical symptoms of the disease. Specialists have also looked into the combined use of atazanavir and ritonavir, another drug used to fight HIV.
The study was published this Monday (April 6) on the BiorXiv international plataform, in preprint version, following the trend of the study and of the repositioning of drugs in the battle against…
Article
The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the WHO and Fiocruz, the unit will now begin making confirmatory tests for the disease in the region, and will also join the WHO network of laboratory specialists for Covid-19.
National reference in respiratory viruses for the Ministry of Health, the Laboratory has been working hard since the emergence of the novel coronavirus (SARS-COV-2) to…
Article
On this Tuesday, April 14th is celebrated for the first time as the World Chagas Day, after being recognized in 2019 by the World Health Organization (WHO). To mark the day that remembers the first case diagnosed in humans by Fiocruz researcher Carlos Chagas, in 1909, leaders of Global Health have prepared a video.
It is estimated that 6 to 7 million people worldwide suffer from Chagas disease, between 2 and 3 million of them live in Brazil. World Day reminds us that these people need access to early diagnosis and adequate treatment. As we face the pandemic of the new coronavirus, these…
Article
With the aim of presenting innovative initiatives to respond to the pandemic, researchers from the Foundation participated, on March 31, in a virtual workshop with Portuguese-speaking countries, organized by the Research Capacity Network (REDe) and the sharing knowledge base incorporated into the online platform The Global Health Network, from the University of Oxford. The platform aims to provide research resources, courses and other tools that can support scientists to carry out their investigations in places where these resources are scarce.
Alongside Jocelyne de Vasconcellos, from…
Article
Começou a funcionar esta semana um espaço dedicado ao planejamento e à constituição das equipes de gestores do novo Centro Hospitalar para a Pandemia de Covid-19 - Instituto Nacional de Infectologia, em adiantado estágio de construção. O quarto andar da Escola Nacional de Saúde Pública Sergio Arouca (Ensp), no Campus Manguinhos, foi adaptado para essa finalidade.
Amanhã (16/4), equipes do INI estarão no local para dar início às entrevistas com os candidatos às vagas abertas para o hospital. É a segunda etapa do processo seletivo, iniciado por meio de edital lançado pela Fundação…
Article
Matéria publicada no site Periferia em movimento.
Article
Artigo Publicado no Vio Mundo.
Article
Artigo publicado no Le Monde Diplomatique Brasil.
Article
Enhancing the actions of the Oswaldo Cruz Foundation (Fiocruz) in the view of the new coronavirus pandemic (Sars-CoV-2) by joining the forces of the public and private sectors. This is the goal of the United against Covid-19 program launched by Fiocruz on April 2nd, opening a channel for companies, organizations and individuals interested in being a part of the network of supporters for the initiatives developed by the institution, all over the country, to face this public health emergency.
The donations obtained will be supporting projects and actions that include the construction of…
Article
A Presidência da Fiocruz, por meio das vice-presidências VPPIS, VPPCB e VPGDI, abre as inscrições nesta terça-feira (21/4) para a seleção de projetos oriundos das unidades e escritórios da Fundação, como parte do Programa Fiocruz de Fomento à Inovação – Inova Fiocruz, para projetos de pesquisa em áreas estratégicas com foco na pandemia de Covid-19.
Edital Ideias e Produtos Inovadores - Covid-19
Esse Edital, para servidores Fiocruz, tem o objetivo de apoiar propostas voltadas para a pandemia da Covid-19 que possam trazer ações, decisões e respostas rápidas. A inclusão de grupos externos é bem-…
Article
A group of researchers of the Oswaldo Cruz Foundation (Fiocruz) and of the Getulio Vargas Foundation (FGV) has just released a report on the risk of Covid-19 dissemination among indigenous populations, due to the geographic and sociodemographic vulnerability of this segment of the Brazilian population. According to the study, the arrival of Covid-19 has imposed many challenges to indigenous communities, to health authorities and to society as a whole, to promote the protection of these populations against the disease, which can have great social and health impact. As the disease moves to…
Article
The number of deaths caused by Covid-19 has doubled every 5 days in Brazil, on average. In the United States and in Ecuador, countries with high dissemination rates, the interval necessary for this duplication is an average of 6 days. In Italy and in Spain, 8 days.
This is one of the figures released by the most recent technical paper of MonitoraCovid-19, a system that groups and provides data on the pandemic of the new coronavirus in Brazil. Epidemiologists, geographers and statistitians of the Institute of Scientific and Technological Communication and Information in Health (Icict/…
Article